Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Morningstar report on TD Waterhouse

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Oct 06, 2024 9:52am

155 Views

Post# 36254997

RE:RE:Morningstar report on TD Waterhouse

All good info and fair points.

Range bound price controls appear to still be in effect for whatever reason (eg last round of financing approaching with associated handouts, continued and deliberate effort in staying off the radar until Baxter CG does there thing, etc. )
The FUD group still has a small but diminshing role to play in this regard. 3 months from ETA on Top Line data release will be a different story, I suspect.

Lost about a month of time as August and Sept came through a little light in terms of enrollment, but as BJ says we're still averaging > 6 YTD ( I love a guy that can do math - it's just so darn attractive!)

Chees,
MM